Meningeal melanocytoma

Meningeal melanocytoma is a rare, typically benign pigmented tumor arising from melanocytes within the leptomeninges (the membranes surrounding the brain and spinal cord). These melanocytes are normally present in the meninges and are derived from the neural crest during embryonic development. Meningeal melanocytoma is classified as a low-grade (Grade I) melanocytic neoplasm of the central nervous system, distinguishing it from the more aggressive primary meningeal melanoma. The tumor most commonly occurs in the posterior fossa, spinal cord (particularly the thoracic region), and around Meckel's cave, though it can arise at any meningeal site. Symptoms depend on the tumor's location and size and result from compression of adjacent neural structures. Patients may experience headaches, seizures, focal neurological deficits, spinal cord compression symptoms (such as weakness, sensory changes, or bowel and bladder dysfunction), cranial nerve palsies, or signs of increased intracranial pressure. The tumor typically presents as a well-circumscribed, heavily pigmented mass that may be mistaken radiologically for a meningioma. The primary treatment for meningeal melanocytoma is complete surgical resection, which is often curative when achievable. However, complete removal may be difficult depending on the tumor's location and its relationship to critical neural and vascular structures. In cases of incomplete resection, adjuvant radiation therapy may be considered to reduce the risk of recurrence. Although generally benign, meningeal melanocytomas can occasionally recur and, in rare instances, undergo malignant transformation to meningeal melanoma. Long-term follow-up with serial imaging is therefore recommended. There are no established chemotherapy regimens for this tumor, and management decisions are typically made on a case-by-case basis.

Common questions about Meningeal melanocytoma